Publication: Characterizing blood-stage antimalarial drug mic values in vivo using reinfection patterns
Issued Date
2018-07-01
Resource Type
ISSN
10986596
00664804
00664804
Other identifier(s)
2-s2.0-85049045950
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antimicrobial Agents and Chemotherapy. Vol.62, No.7 (2018)
Suggested Citation
James Watson, Cindy S. Chu, Joel Tarning, Nicholas J. Whitea Characterizing blood-stage antimalarial drug mic values in vivo using reinfection patterns. Antimicrobial Agents and Chemotherapy. Vol.62, No.7 (2018). doi:10.1128/AAC.02476-17 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46566
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Characterizing blood-stage antimalarial drug mic values in vivo using reinfection patterns
Other Contributor(s)
Abstract
Copyright © 2018 Watson et al. The MIC is an essential quantitative measure of the asexual blood-stage effect of an antimalarial drug. In areas of high malaria transmission, and thus frequent individual infection, patients who are treated with slowly eliminated antimalarials become reinfected as drug concentrations decline. In the frequent relapse forms of Plasmodium vivax and in Plasmodium ovale malaria, recurrent infection occurs from relapses which begin to emerge from the liver approximately 2 weeks after the primary illness. An important determinant of the interval from starting treatment of a symptomatic infection to the patency of these recurrent infections is the in vivo concentration-response relationship and thus the in vivo MIC. Using mechanistic knowledge of parasite asexual replication and the pharmacokinetic and pharmacodynamic properties of the antimalarial drugs, a generative statistical model was derived which relates the concentration-response relationship to time of reinfection patency. This model was used to estimate the in vivo MIC of chloroquine in the treatment of Plasmodium vivax malaria.